Those who follow my work closely know that I have been a big fan of pharmaceutical firm Eli Lilly and Company (NYSE: LLY ) for a little while now. My first article about the company, published in June 2023, touted it asCrude Value Insights offers you an investing service and community focused on oil and natural gas. We focus on cash flow and the companies that generate it, leading to value and growth prospects with real potential.Subscribers get to use a 50+ stock model account, in-depth cash flow analyses ...